StratDeck

Two stocks in Healthcare

Amgen vs Vertex Pharmaceuticals: profit, growth, debt and price compared

Vertex Pharmaceuticals is stronger on 4 of 6 figures: profit margin, sales growth, debt and analysts' view. Amgen is stronger on 2: price for its expected profit and price trend.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore Amgen's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Amgen and Vertex Pharmaceuticals side by side
AmgenAMGNVertex PharmaceuticalsVRTX
Net margin24.1%Stronger: 30.7%
Revenue growth, past year+8.45%Stronger: +11.85%
Debt to equity376.3%Stronger: 31.0%
Forward P/EStronger: 17.7×26.9×
Dividend yield2.27%—
AnalystsHold · 29Stronger: Buy · 28
From its 200-day averageStronger: +14.8%+8.8%

Share price over the past year

  • Amgen+29.0%
  • Vertex Pharmaceuticals+23.2%

18 Nov 202518 Nov 2026

Amgen or Vertex Pharmaceuticals: which is stronger?

  • VRTX

    Which is more profitable?

    Vertex Pharmaceuticals keeps more of each sale as profit: 30.7% against 24.1%.

  • VRTX

    Which is growing its sales faster?

    Vertex Pharmaceuticals is growing its sales faster: +11.85% over the past year, against +8.45%.

  • VRTX

    Which has borrowed less?

    Vertex Pharmaceuticals has borrowed less: its debt is 31.0% of what its shareholders own, against 376.3% for Amgen.

  • AMGN

    Which costs less for the profit it is expected to make?

    Amgen costs less for the profit it is expected to make: 17.7× its forward earnings, against 26.9×.

  • Which pays more in dividends?

    Amgen pays 2.27% a year in dividends for what a share costs, where Vertex Pharmaceuticals pays none.

  • VRTX

    Which do analysts rate higher?

    Analysts are warmer on Vertex Pharmaceuticals: Buy, against Hold for Amgen.

  • AMGN

    Which is in the stronger price trend?

    Amgen's price is in the stronger trend: 14.8% above its 200-day average, against 8.8% above.

What each company does

AMGNAmgen

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Reports results on 2 February 2027

VRTXVertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally.

Reports results on 11 February 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.